These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1677014)

  • 1. Atopic dermatitis: new therapeutic considerations.
    Hanifin JM
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1097-101. PubMed ID: 1677014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Levels of Sphingosine, Sphinganine and Their Ceramides in Atopic Dermatitis Are Related to Skin Barrier Function, Disease Severity and Local Cytokine Milieu.
    Toncic RJ; Jakasa I; Hadzavdic SL; Goorden SM; Vlugt KJG; Stet FS; Balic A; Petkovic M; Pavicic B; Zuzul K; Marinovic B; Kezic S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophysiology of atopic dermatitis.
    Hanifin JM
    Clin Rev Allergy; 1986 Feb; 4(1):43-65. PubMed ID: 3008974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentle cleansing and moisturizing for patients with atopic dermatitis and sensitive skin.
    Cheong WK
    Am J Clin Dermatol; 2009; 10 Suppl 1():13-7. PubMed ID: 19209949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation of the non-lesional dry skin in atopic dermatitis by acute barrier disruption: an abnormal permeability barrier homeostasis with defective processing to generate ceramide.
    Sugiura A; Nomura T; Mizuno A; Imokawa G
    Arch Dermatol Res; 2014 Jul; 306(5):427-40. PubMed ID: 24271939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march.
    Egawa G; Kabashima K
    J Allergy Clin Immunol; 2016 Aug; 138(2):350-358.e1. PubMed ID: 27497277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?
    Melnik BC
    Exp Dermatol; 2014 Oct; 23(10):696-700. PubMed ID: 24889007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis.
    Hansson L; Bäckman A; Ny A; Edlund M; Ekholm E; Ekstrand Hammarström B; Törnell J; Wallbrandt P; Wennbo H; Egelrud T
    J Invest Dermatol; 2002 Mar; 118(3):444-9. PubMed ID: 11874483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atopic dermatitis. Special clinical complications.
    Hanifin JM
    Postgrad Med; 1983 Sep; 74(3):188-93, 196-9. PubMed ID: 6193504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a protein-free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients.
    Wollenberg A; Fölster-Holst R; Saint Aroman M; Sampogna F; Vestergaard C
    J Eur Acad Dermatol Venereol; 2018 Apr; 32 Suppl 1():1-15. PubMed ID: 29533490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
    Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
    J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.
    Suárez AL; Feramisco JD; Koo J; Steinhoff M
    Acta Derm Venereol; 2012 Jan; 92(1):7-15. PubMed ID: 22101513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice.
    Ohsawa Y; Hirasawa N
    Allergy; 2012 Aug; 67(8):1014-22. PubMed ID: 22686688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study.
    Ohsawa Y; Hirasawa N
    Allergol Int; 2014 Dec; 63(4):533-42. PubMed ID: 25249063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergetic effects of prednisolone and olopatadine on atopic dermatitis model of hairless mice.
    Kagawa Y; Izawa K; Yano H; Kamei C
    Pharmacology; 2010; 85(5):286-94. PubMed ID: 20453552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiopathogenesis of atopic dermatitis--an overview.
    Pastar Z; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2005; 13(1):54-62. PubMed ID: 15788148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin mast cell releasability in dogs with atopic dermatitis.
    DeMora F; García G; Puigdemont A; Arboix M; Ferrer L
    Inflamm Res; 1996 Aug; 45(8):424-7. PubMed ID: 8872517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis.
    Rossbach K; Schaper K; Kloth Ch; Gutzmer R; Werfel T; Kietzmann M; Bäumer W
    Allergy; 2016 Feb; 71(2):189-97. PubMed ID: 26440543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis.
    Yoshioka T; Hikita I; Asakawa M; Hirasawa T; Deguchi M; Matsutani T; Oku H; Horikawa T; Arimura A
    Immunology; 2006 Jul; 118(3):293-301. PubMed ID: 16827890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of preventing effect of systemically and topically administered histamine H(1) or H(4) receptor antagonists in a dog model of acute atopic dermatitis.
    Bäumer W; Stahl J; Sander K; Petersen LJ; Paps J; Stark H; Kietzmann M; Olivry T
    Exp Dermatol; 2011 Jul; 20(7):577-81. PubMed ID: 21521369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.